Women's Health Innovation Summit 2020 | Kisaco Research

Women's Health Innovation Summit

Strengthening the Women's Healthcare network, boosting investments & accelerating innovation

Download 2020 Agenda
VIRTUAL SUMMIT | EDT Timezone
14-22 September, 2020

“When I lie awake thinking of women and their health globally, I remind myself: the world has made a lot of progress in recent years…Too many women are still missing out on the opportunity to get educated, support themselves, and obtain the health services they need, when they need them”

Dr Flavia Bustreo, Assistant Director General for Family, Women’s and Children’s Health through the Life-course, World Health Organization

WHY ATTEND?

Women’s health today is under-served from an innovation and clinical science standpoints with outdated practices and lack of much-needed attention from key players (incl. investors and insurers). It is imperative to develop the eco-system, shift mindsets and embrace the holistic women-centred approach.

The Women’s Health Innovation Summit (WHI) is THE forum for pharmaceutical and medical devices companies, start-ups and investors, doctors, researchers and HCPs, employers and insurers to drive innovation at the convergence of healthcare and technology.

We tackle the female prevalent verticals (e.g. contraception, pregnancy, breast cancer, and fertility), as well as other verticals including cardiovascular diseases, inconsistency, diabetes, mental health, sexual health amongst others.

This event is for strengthening and advancing research, investments and partnerships to ultimately improve the access and quality of healthcare for women worldwide.

To make the difference and to move your business forward, join us!

4
Days
55+
Industry Leading Speakers
10+
Dedicated Networking Hours
5+
In-depth Case Studies
250+
Industry Executives

10 Highlights of WHIS 2020:

1. Understand the barriers to success and innovation in women’s health, and how to overcome them.

2. How Tech and Healthcare can collaborate to scale health solutions in unprecedented way.

3. Breakthrough Innovations:

  • Investors: Identify your next acquisition target/opportunity. Meet the top innovators across therapies, digital innovations/telehealth, devices, AI and wearables. 
  • Emerging Brands: Showcase your innovations, gain exposure to the wider universe of investors/partners.

4. Discover Unmet Needs: Deepen your understanding and hear from leading doctors, clinicians & heads of women’s health in hospitals.

5. Provide a holistic women-centred approach to healthcare that goes beyond treatment. Learn more about customers’ preferences, advertising regulations and marketing strategies.

6. Finance & Investments: Learn financial and investors’ strategies in the field and an in-depth look at what they are looking for in Women’s Health.

7. Address the needs of women across the generational gap and speaking to them in a language that resonates through personalized customer interactions

8. Developing Eco-system: meet all the stakeholders to strengthen the women's health network and accelerate solutions for your commercial success

9. Focus on Diseases & Issues: gain actionable intelligence on innovations in contraception, fertility, vaginal health and microbiome, pregnancy care and delivery, breast cancer treatment and rehabilitation, abortion, menopause and menstrual cycle, mental health, inconsistency disorders, urogynaecology, diabetes, maternal and sexual health.

10. Studies, Clinical Validation & Hospital Partnerships: Hear from leading organisations organising inclusive studies, working with data successfully and pushing the barriers in advancing women’s health.

45%
Pharma/Biotech/Digital Health/Med Device/Diagnostics
30%
Start-ups
10%
Service Providers
10%
Investors
5%
Payors/Insurers/Employers

Pharma/Biotech/Digital Health/Med Device/Diagnostics

Start-ups

Service Providers

Investors

Payors/Insurers/Employers

75+ Leaders in Women's Health

 

Sabrina Johnson

President and Chief Executive Officer
Daré Bioscience

Ms. Johnson founded Daré Bioscience Operations, Inc. in 2015 and has served as President, CEO and a member of the Board of Directors since its inception and following its business combination with Cerulean Pharma Inc. on July 19, 2017, when the Company was renamed Daré Bioscience, Inc. Ms. Johnson is a life sciences executive committed to advancing improvements in women’s healthcare.

Sabrina Johnson

President and Chief Executive Officer
Daré Bioscience

Sabrina Johnson

President and Chief Executive Officer
Daré Bioscience

Ms. Johnson founded Daré Bioscience Operations, Inc. in 2015 and has served as President, CEO and a member of the Board of Directors since its inception and following its business combination with Cerulean Pharma Inc. on July 19, 2017, when the Company was renamed Daré Bioscience, Inc. Ms. Johnson is a life sciences executive committed to advancing improvements in women’s healthcare.

Previously, Ms. Johnson served as President of WomanCare Global Trading, a specialty pharmaceutical company in female reproductive healthcare with commercial product distribution in over 100 countries, from October of 2014 to May of 2015, and Chief Financial Officer and Chief Operating Officer from July 2013 to October 2014. Ms. Johnson provided financial consulting services to the WomanCare Global family of companies, including the United Kingdom-based non-profit division, from November 2012 to July 2013. From 2002 until its sale in 2010, Ms. Johnson served as Chief Financial Officer of Cypress Bioscience, Inc., a publicly-traded pharmaceutical company, and in addition served as its Chief Operating Officer from 2008 until its sale in 2010. Ms. Johnson began her career in the biotechnology industry as a research scientist with Baxter Healthcare, Hyland Division, working on their recombinant factor VIII program, and later held marketing and sales positions with Advanced Tissue Sciences and Clonetics Corporation.

Ms. Johnson currently serves on the boards of Aethlon Medical, Inc., a publicly-traded company developing immunotherapeutic technologies to combat infectious disease and cancer; the YWCA of San Diego County as Past President, Athena San Diego, BIOCOM, and the Clearity Foundation as incoming Chair. Additionally. Ms. Johnson serves on the Board of Advisors of Tulane University School of Science & Engineering and on the Audit Committee of Project Concern International.

Ms. Johnson has a Masters of International Management degree with honors from the American Graduate School of International Management (Thunderbird), a MSc in Biochemical Engineering from the University of London, University College London and a BSc in Biomedical Engineering from Tulane University, where she graduated magna cum laude.

 

Al Altomari

Chairman and CEO
Agile Therapeutics

Mr. Altomari has served as our Chairman of the board and Chief Executive Officer since October 2016 and has been a member of our board of directors since February 2004. Mr. Altomari served as President and Chief Executive Officer from 2010 to 2016. Previously Mr. Altomari served as Agile's Executive Chairman from 2004 to 2010. From 2003 to 2008, Mr. Altomari held multiple senior management positions at Barrier Therapeutics, Inc., including Chief Commercial Officer, Chief Operating Officer, and Chief Executive Officer.

Al Altomari

Chairman and CEO
Agile Therapeutics

Al Altomari

Chairman and CEO
Agile Therapeutics

Mr. Altomari has served as our Chairman of the board and Chief Executive Officer since October 2016 and has been a member of our board of directors since February 2004. Mr. Altomari served as President and Chief Executive Officer from 2010 to 2016. Previously Mr. Altomari served as Agile's Executive Chairman from 2004 to 2010. From 2003 to 2008, Mr. Altomari held multiple senior management positions at Barrier Therapeutics, Inc., including Chief Commercial Officer, Chief Operating Officer, and Chief Executive Officer. In 2008, in his role as Chief Executive Officer and as a member of Barrier's board of directors, Mr. Altomari completed the successful sale of Barrier to Stiefel Laboratories, which was subsequently acquired by GlaxoSmithKline plc. From 1982 to 2003, Mr. Altomari held numerous executive roles in general management, commercial operations, business development, product launch preparation, and finance with Johnson & Johnson. Mr. Altomari also serves on the board of directors of Insmed Inc. and Baudax Bio, Inc. He previously served on the board of directors of Recro Pharm, Inc. Mr. Altomari received an M.B.A. from Rider University and his B.S. from Drexel University. He currently serves on the LeBow College of Business Advisory Board and the Board of the Charles D. Close School of Entrepreneurship at Drexel University. He currently is a member of the Board of Directors for TASK (Trenton Area Soup Kitchen).

 

 

David Portman

Founder, CEO and Medical Director
Sermonix Pharmaceuticals

Founder, CEO and Medical Director of Sermonix Pharmaceuticals.
Director Emeritus of a Clinical Research Center with research interests in menopause, sexual dysfunction, hormone replacement therapy, SERMs, osteoporosis, contraception and gynecologic endocrinology. Conducted over 140 clinical trials in women’s health.
Lectures nationally, internationally and consults widely on women’s health issues, and is on numerous advisory boards. Board-certified Obstetrician/Gynecologist.

David Portman

Founder, CEO and Medical Director
Sermonix Pharmaceuticals

David Portman

Founder, CEO and Medical Director
Sermonix Pharmaceuticals

Founder, CEO and Medical Director of Sermonix Pharmaceuticals.
Director Emeritus of a Clinical Research Center with research interests in menopause, sexual dysfunction, hormone replacement therapy, SERMs, osteoporosis, contraception and gynecologic endocrinology. Conducted over 140 clinical trials in women’s health.
Lectures nationally, internationally and consults widely on women’s health issues, and is on numerous advisory boards. Board-certified Obstetrician/Gynecologist.

 

Angie Kalousek Ebrahimi

Executive Director, Mind-Body Medicine
Blue Shield of California

Angie Kalousek Ebrahimi oversees the sales and marketing of clinically proven lifestyle medicine programs for Blue Shield of California’s members. Angie and her team work to drive both enrollment and engagement in the lifestyle medicine interventions under the Wellvolution brand. Angie strongly believes that lifestyle medicine can transform the current health care model by introducing clinically effective, cost effective and non-invasive lifestyle approaches into the care continuum.

Angie Kalousek Ebrahimi

Executive Director, Mind-Body Medicine
Blue Shield of California

Angie Kalousek Ebrahimi

Executive Director, Mind-Body Medicine
Blue Shield of California

Angie Kalousek Ebrahimi oversees the sales and marketing of clinically proven lifestyle medicine programs for Blue Shield of California’s members. Angie and her team work to drive both enrollment and engagement in the lifestyle medicine interventions under the Wellvolution brand. Angie strongly believes that lifestyle medicine can transform the current health care model by introducing clinically effective, cost effective and non-invasive lifestyle approaches into the care continuum. She, herself, has incorporated lifestyle medicine into her own life to prevent disease and live in optimal health. Angie is strategically working to forward Blue Shield of California’s philosophy that lifestyle is medicine.

Prior to joining Blue Shield in 2010, Angie worked as the Wellness Program Manager at Visa, Inc. where she created and implemented a new suite of global wellness programs for Visa employees. Part of her role at Visa was to incorporate Visa wellness programming with health plan offerings so that employees had a seamless experience. Prior to her time at Visa, Angie served as the Fitness Director at the Sports Club LA in San Francisco where she oversaw a staff of 60 trainers, nutritionists, and sports coordinators. In her role there, she also managed new member fitness programs, trainer education and direct private training sales. Angie has also worked in marketing, business planning and accounting.

Angie holds an MBA from Golden Gate University, a BS in Business from the University of California, Haas School of Business, Berkeley, and is a Certified Holistic Lifestyle Coach. 

 

Nelson Ambrogio

Senior Vice President and General Manager Women’s Healthcare
Bayer Pharmaceuticals US

Nelson is a highly-respected and dynamic business leader who is dedicated to delivering innovative health care solutions to enhance people’s lives.

Nelson Ambrogio

Senior Vice President and General Manager Women’s Healthcare
Bayer Pharmaceuticals US

Nelson Ambrogio

Senior Vice President and General Manager Women’s Healthcare
Bayer Pharmaceuticals US

Nelson is a highly-respected and dynamic business leader who is dedicated to delivering innovative health care solutions to enhance people’s lives.


As the leader of the Bayer Women’s Healthcare team, he is responsible for Bayer’s leading contraceptive portfolio, with revenues in excess of 900m$ and leading a cross-functional organization of more than 300 team members.
In his previous role, Nelson led the Bayer Pharmaceuticals team in Australia and New Zealand, where he was responsible for the launch of blockbuster drugs including Xarelto (cardiovascular) and Eylea (ophthalmology) and guiding a team of more than 250 people.


Nelson’s career spans more than 20 years with Bayer and Schering in both mature and emerging markets across Latin America, Europe and Australasia. He has held the position of managing director of Bayer Portugal, business unit director General Medicine, Bayer Brazil and assistant to a Bayer Board Member at the company’s headquarters in Germany.
Nelson started his career at Schering in his native Uruguay and was instrumental in the program management of the Bayer-Schering integration in Latin America and Canada.

 

Lynn Seely MD

CEO
Myovant Sciences

Lynn Seely, MD, is the Chief Executive Officer of Myovant Sciences, a healthcare company focused on developing innovative treatments for women’s health and prostate cancer. Dr. Seely is an endocrinologist with over 20 years of drug development and executive leadership experience. Prior to Myovant, she served as Chief Medical Officer at Medivation from 2005-2015 and led the development of XTANDI® (enzalutamide) for the treatment of metastatic castration-resistant prostate cancer from IND-enabling studies through to NDA approval and post-approval clinical studies.

Lynn Seely MD

CEO
Myovant Sciences

Lynn Seely MD

CEO
Myovant Sciences

Lynn Seely, MD, is the Chief Executive Officer of Myovant Sciences, a healthcare company focused on developing innovative treatments for women’s health and prostate cancer. Dr. Seely is an endocrinologist with over 20 years of drug development and executive leadership experience. Prior to Myovant, she served as Chief Medical Officer at Medivation from 2005-2015 and led the development of XTANDI® (enzalutamide) for the treatment of metastatic castration-resistant prostate cancer from IND-enabling studies through to NDA approval and post-approval clinical studies.

Dr. Seely currently serves on the Board of Directors of Blueprint Medicines Corporation. She completed her residency in internal medicine at Yale-New Haven Hospital and a basic science and clinical fellowship in endocrinology and metabolism at the University of California, San Diego.

 

Susan C. Nicholson, MD, FIDSA

Vice President, Women’s Health
Johnson & Johnson

Susan C. Nicholson, MD, FIDSA

Vice President, Women’s Health
Johnson & Johnson

Susan C. Nicholson, MD, FIDSA

Vice President, Women’s Health
Johnson & Johnson
 

Alice Zheng, MD, MBA, MPH

Women’s Health Practice Leader
McKinsey & Company

Alice Zheng, MD, MBA, MPH

Women’s Health Practice Leader
McKinsey & Company

Alice Zheng, MD, MBA, MPH

Women’s Health Practice Leader
McKinsey & Company
 

Stephen Gerrard

Program Officer
Bill & Melinda Gates Foundation

Stephen Gerrard

Program Officer
Bill & Melinda Gates Foundation

Stephen Gerrard

Program Officer
Bill & Melinda Gates Foundation
 

Luba Greenwood

Co-Founder & Board Member, Former Strategic BD & Corporate Ventures at Verily
LUCA

Luba Greenwood

Co-Founder & Board Member, Former Strategic BD & Corporate Ventures at Verily
LUCA

Luba Greenwood

Co-Founder & Board Member, Former Strategic BD & Corporate Ventures at Verily
LUCA
 

Andrea S. Lukes, MD, MHSc, FACOG

Chief Medical Officer
Health Decisions

Dr. Andrea S. Lukes is a board-certified OB/GYN, a Fellow of The American Congress of Obstetricians and Gynecologists and an expert on clinical development of women’s health products across a wide range of indications across the female lifecycle. Her areas of expertise include but are not limited to endometrial ablation, endometriosis, hysteroscopy, minimally invasive gynecology, bleeding disorders, uterine fibroids, contraception, menopause and vasomotor symptoms, hereditary cancer screening and prenatal counseling. Dr.

Andrea S. Lukes, MD, MHSc, FACOG

Chief Medical Officer
Health Decisions

Andrea S. Lukes, MD, MHSc, FACOG

Chief Medical Officer
Health Decisions

Dr. Andrea S. Lukes is a board-certified OB/GYN, a Fellow of The American Congress of Obstetricians and Gynecologists and an expert on clinical development of women’s health products across a wide range of indications across the female lifecycle. Her areas of expertise include but are not limited to endometrial ablation, endometriosis, hysteroscopy, minimally invasive gynecology, bleeding disorders, uterine fibroids, contraception, menopause and vasomotor symptoms, hereditary cancer screening and prenatal counseling. Dr. Lukes advises Health Decisions and our clients on development and implementation of research protocols as well as communications and presentations to the FDA.

 

An experienced principal investigator in industry-sponsored, NIH and CDC clinical trials, Dr. Lukes has conducted or overseen more than 90 clinical trials of investigational women’s health products, including both drugs and devices. Recent experience includes studies of sedation during hysteroscopic tissue removal, treatment of anemia associated with uterine leiomyomas, treatment of vulvovaginal atrophy, transcervical ablation of uterine fibroids, combination drug therapy for management of menstrual bleeding associated with uterine fibroids in premenopausal women, a vapor treatment for excessive uterine bleeding, analgesia for endometriosis-associated pain, pain management during endometrial biopsy, and migraine.

 

Dr. Lukes’ articles have appeared in journals including Obstetrics and Gynecology, the American Journal of Obstetrics and Gynecology, Fertility and Sterility, the Journal of Minimally Invasive Gynecology, Women’s Health, Women’s Healthcare, Contemporary OB/GYN, the International Journal of Women’s Health, Cancer, the British Journal of Hematology, the Journal of Medicine, Current Medical Research & Opinion and Drug Safety. She has served on advisory committees for FDA meetings on topics including a clinician’s perspective on thromboembolism, heavy menstrual bleeding and alkaline hematin assessment, and clinical trial design for treatment of vaginal laxity and female sexual dysfunction.

 

Dr. Lukes founded the Carolina Women’s Research and Wellness Center (CWRWC), a leading private gynecologic practice and clinical research center. She also co-founded and served as the Director of Gynecology for the Women’s Hemostasis and Thrombosis Clinic at the Duke University Medical Center and founded and chaired the OB/GYN Alliance, an online network of 8,000 OB/GYN physicians in the United States.

 

Dr. Lukes received a bachelor’s degree and a combined medical degree and master’s degree in statistics from Duke University. She completed her residency at the University of North Carolina School of Medicine.

 

Jannine Versi

Co-Founder & CEO
Elektra Health

Jannine Versi

Co-Founder & CEO
Elektra Health

Jannine Versi

Co-Founder & CEO
Elektra Health
 

Barbara Dehn

Women’s Health Nurse Practitioner, Silicon Valley
Bayer Pharmaceuticals

Barb Dehn is a practicing Women’s Health Nurse Practitioner in Silicon Valley and a television health expert, who’s known as Nurse Barb on NBC’s California Live. An award winning author, active in Social Media and YouTube, Barb earned a masters degree from UCSF and a BS from Boston College. She is certified by the North American Menopause Society and is a Fellow in the American Association of Nurse Practitioners.  She works on Global Health Initiatives at FAME Hospital in Karatu, Tanzania, where she serves on their board and as a volunteer.

 

Barbara Dehn

Women’s Health Nurse Practitioner, Silicon Valley
Bayer Pharmaceuticals

Barbara Dehn

Women’s Health Nurse Practitioner, Silicon Valley
Bayer Pharmaceuticals

Barb Dehn is a practicing Women’s Health Nurse Practitioner in Silicon Valley and a television health expert, who’s known as Nurse Barb on NBC’s California Live. An award winning author, active in Social Media and YouTube, Barb earned a masters degree from UCSF and a BS from Boston College. She is certified by the North American Menopause Society and is a Fellow in the American Association of Nurse Practitioners.  She works on Global Health Initiatives at FAME Hospital in Karatu, Tanzania, where she serves on their board and as a volunteer.

 

 

Tenesha Duncan

Principal, Maternal Health
Tara Health Foundation

Tenesha Duncan

Principal, Maternal Health
Tara Health Foundation

Tenesha Duncan

Principal, Maternal Health
Tara Health Foundation
 

Elizabeth Garner

Chief Medical Officer
ObsEva

Elizabeth Garner

Chief Medical Officer
ObsEva

Elizabeth Garner

Chief Medical Officer
ObsEva
 

Allison Conti

Founder/CEO
Watkins-Conti Products

Allison was raised in an entrepreneurial environment where she witnessed the formation and creation of sustainable businesses. The industries ranged from oil & gas exploration and development to retail, cattle ranching and commercial real estate. Allison began her professional career in print media marketing and advertising. She then transitioned to a successful career in the radio and television industry. Allison also owned and managed a small business in the construction trades. She has experience in many facets of business management.

Allison Conti

Founder/CEO
Watkins-Conti Products

Allison Conti

Founder/CEO
Watkins-Conti Products

Allison was raised in an entrepreneurial environment where she witnessed the formation and creation of sustainable businesses. The industries ranged from oil & gas exploration and development to retail, cattle ranching and commercial real estate. Allison began her professional career in print media marketing and advertising. She then transitioned to a successful career in the radio and television industry. Allison also owned and managed a small business in the construction trades. She has experience in many facets of business management.


In 2015, Allison conceived a solution for an issue that affects over 498 million women, worldwide. The passion and drive for this venture is based on personal experience. She designed, patented, engineered and manufactured a solution that is entering the FDA approval process. Allison has secured seed funding to create a quality management system, a contract manufacturing facility, conduct a feasibility study validating efficacy, and employ some of the top industry leaders in the United States.
Today, Allison develops products to address issues facing women across the globe. Allison is dedicated to the innovation and development of affordable, effective solutions for common life-altering difficulties faced in today’s environment.

 

Chandra P. Leo

Partner
HBM Partners

Chandra P. Leo is a member of the private equity team at HBM Partners, a Swiss-based healthcare investment firm with approximately $1.8 billion in assets under management. He has been responsible for investments in more than 15 private biotech, medical device and diagnostics companies in the United States and Europe, in most cases as a board member or board observer. Collectively, these companies have so far generated five NASDAQ IPOs, five M&A transactions and four FDA-approved marketed products.

 

Chandra P. Leo

Partner
HBM Partners

Chandra P. Leo

Partner
HBM Partners

Chandra P. Leo is a member of the private equity team at HBM Partners, a Swiss-based healthcare investment firm with approximately $1.8 billion in assets under management. He has been responsible for investments in more than 15 private biotech, medical device and diagnostics companies in the United States and Europe, in most cases as a board member or board observer. Collectively, these companies have so far generated five NASDAQ IPOs, five M&A transactions and four FDA-approved marketed products.

 

In the women’s health field, Chandra has backed and worked with companies focused on e.g. cervical cancer, endometriosis, uterine fibroids, gynecologic infections, urogynecologic conditions, infertility and preterm labor. Before becoming a venture capital investor, he served as a physician in the Dept. of OB/GYN at the University Hospital in Leipzig, Germany, and completed a postdoctoral fellowship in reproductive biology at Stanford University.

 

Chandra holds degrees as a Doctor of Medicine from the Freie Universität Berlin (Charité), a Master in Medicines Development (MAS) from the University of Basel, and an MBA with distinction from INSEAD (France/Singapore). He lives in Zurich with his wife (a gynecologist) and their two daughters.  

 

 

Bill Gruber

CEO
Solace Therapeutics

Bill Gruber joined Solace Therapeutics in August 2011 as President and CEO. Prior to this role, he co-founded Interlace Medical in August 2006 and served as their President and CEO until Interlace was acquired by Hologic in January 2011. Bill has extensive experience in organizational development and in product development for rapid growth businesses. Prior to Interlace, Bill spent five years at Cortek Inc., a spinal products company. As Cortek’s V.P. of Sales and Marketing, he built sales from $612K to over $10M.  During his last two years, he was the V.P.

Bill Gruber

CEO
Solace Therapeutics

Bill Gruber

CEO
Solace Therapeutics

Bill Gruber joined Solace Therapeutics in August 2011 as President and CEO. Prior to this role, he co-founded Interlace Medical in August 2006 and served as their President and CEO until Interlace was acquired by Hologic in January 2011. Bill has extensive experience in organizational development and in product development for rapid growth businesses. Prior to Interlace, Bill spent five years at Cortek Inc., a spinal products company. As Cortek’s V.P. of Sales and Marketing, he built sales from $612K to over $10M.  During his last two years, he was the V.P. of New Business Development and Marketing. In this role, he was instrumental in creating Soteira, a Cortek subsidiary, focused on devices for treating vertebral compression fractures. Prior to Cortek, Bill spent 10 years at Boston Scientific Corporation. Before leaving Boston Scientific Corporation, he held the position of Director of the $172M Global Atherosclerotic Therapy business. Prior to entering the medical device sector, Bill spent five years in sales and marketing roles at Procter and Gamble.

 

Amy Welsh

Vice President Marketing
Agile Therapeutics

Amy Welsh

Vice President Marketing
Agile Therapeutics

Amy Welsh

Vice President Marketing
Agile Therapeutics
 

Stasia Obremskey

Partner
Rhia Ventures

Before joining, Stasia served in 2018 as the first Fellow of the Tara Health Foundation. She has more than twenty-five years of experience providing financial and strategic planning consulting to organizations in the U.S. and Asia. She has joined management teams as the interim Chief Financial Officer on a short term and extended term basis to provide finance, accounting and strategic planning expertise to startups, fast growing companies and non-profit organizations. Current and past clients include 18Birdies, Posit Science, Circlepoint, West Shore Technologies and We Care Solar.

Stasia Obremskey

Partner
Rhia Ventures

Stasia Obremskey

Partner
Rhia Ventures

Before joining, Stasia served in 2018 as the first Fellow of the Tara Health Foundation. She has more than twenty-five years of experience providing financial and strategic planning consulting to organizations in the U.S. and Asia. She has joined management teams as the interim Chief Financial Officer on a short term and extended term basis to provide finance, accounting and strategic planning expertise to startups, fast growing companies and non-profit organizations. Current and past clients include 18Birdies, Posit Science, Circlepoint, West Shore Technologies and We Care Solar. She has lived for over 8 years in Bangkok, Thailand and Hong Kong, China. She began her consulting career as a management consultant with Bain & Company. Previously, she worked in investment banking for Morgan Stanley & Co. She holds a bachelor’s degree in Business Administration with a concentration in finance from the University of Notre Dame and an MBA from the Harvard Graduate School of Business. In addition to her consulting work, she has extensive experience as a member of several nonprofit boards where she has held a number of leadership positions.

 

Dr Itamar Netzer, OBGYN

Fellow, Healthcare Administration
Ministry of Health, Israel

I am a certified obstetrician and gynecologist, and former Fleet Surgeon of the Israeli Navy (Commander O4, retired). Currently studying Drug and Medical Device Regulation at the Israeli MOH.
I am an analytical, creative and nurturing leader, excelling in creating and maintaining network- or matrix-structure organizations.
My career has the unique characteristics of professional military physicians in Israel, including both high-stakes and decision-making roles in the military, and a full medical professional career in a hospital.

Dr Itamar Netzer, OBGYN

Fellow, Healthcare Administration
Ministry of Health, Israel

Dr Itamar Netzer, OBGYN

Fellow, Healthcare Administration
Ministry of Health, Israel

I am a certified obstetrician and gynecologist, and former Fleet Surgeon of the Israeli Navy (Commander O4, retired). Currently studying Drug and Medical Device Regulation at the Israeli MOH.
I am an analytical, creative and nurturing leader, excelling in creating and maintaining network- or matrix-structure organizations.
My career has the unique characteristics of professional military physicians in Israel, including both high-stakes and decision-making roles in the military, and a full medical professional career in a hospital.

Publication: I am the author or co-author of 15 medical articles and 2 book chapters on the topics of telemedicine, gynecology, or military medicine and presented my academic work extensively in international conferences.
Honors: I was the recipient of two 1st prize awards given by the IDF Chief of the Technology and Logistics Directorate, for Medical Innovation.

My current goals and interests are:
Attaining a leadership position in the medical technology industry, where I may contribute to the future transformation of medical care in terms of personalized, equitable and empathic care driven by advanced tech and caregiver-training. 

 

Jeffrey Erb

President
McCann Health Engagement

Jeffrey D. Erb is the President of McCann Health: Engagement, the healthcare customer engagement agency within McCann Health and part of the IPG Network. McCann Health Engagement is a leading organization across the globe, developing solutions to most effectively engage with healthcare clients through media and the use of proprietary data applications.

 

Jeffrey Erb

President
McCann Health Engagement

Jeffrey Erb

President
McCann Health Engagement

Jeffrey D. Erb is the President of McCann Health: Engagement, the healthcare customer engagement agency within McCann Health and part of the IPG Network. McCann Health Engagement is a leading organization across the globe, developing solutions to most effectively engage with healthcare clients through media and the use of proprietary data applications.

 

Prior to joining McCann Health, Mr. Erb served as the President of HealixGlobal, the healthcare specialty media agency within IPG Mediabrands, with a market presence and offices in over 100 countries. In his role, he led the organization for several consecutive years of over 50% YOY growth, more than tripled the size of the agency, and lead transformational change in the pharmaceutical media industry on a global level. For over 16 years, Jeff has been a leader in Life Sciences and Healthcare marketing and media. After launching a Pharmaceutical marketing company in 1999 which he sold to a healthcare company, he went on to help large media and marketing agencies launch or reignite their own healthcare divisions.

 

His experience in defining new strategies for clients in both HCP and Consumer Life Sciences marketing spans from media and analytics, to digital solutions and global pricing strategies. His work has spanned across a wide range in products and therapeutic categories.

 

His leadership has garnered him a Ben Franklin Award for Most Innovative New Company and he has been featured in numerous television and print news stories, including The Wall Street Journal, Philadelphia Enterpriser Magazine, TSM News, among others, and was named one of the top 100 people to watch by Philadelphia Style Magazine. Most recently he was named a 2019 Top 10 Innovation Catalyst by MM&M Magazine, one of the 2018 Pharma Elite by PM360 Magazine, a Health Influencer 50 by MM&M and received the Innovator of the Year Award from DTC Perspectives. He has also led Healix to win the 3rd Annual Humanitarian Award from Healthcare Marketer’s Exchange and to receive the 2018 Most Innovative Company Award from PM 360.

 

Mr. Erb has frequently spoken nationally as an expert in the fields of media, business development, and technology at events such as Internet World and the Wharton Technology and Media Conference among others. He is a member or has served on the board of numerous business and philanthropic organizations on both a local and National level, including the Medical Marketing Association, and has served as a Director of the Divine Providence Auxiliary Association for handicapped children.

 

On a personal note, Jeff is an avid investor and producer of feature films, a musician, and he enjoys sailing, skiing and spending time with his family.

 

Nathan Guerette

Director & CEO and Director of Robotic Surgery
Female Pelvic Medicine Institute of Virginia and Johnston Willis Hospital

Dr. Nathan Guerette serves as Director and CEO of The Female Pelvic Medicine Institute of Virginia. He is a board certified Urogynecologist specializing in minimally invasive surgical options for pelvic reconstruction and cosmetic surgery including advanced vaginal and robotic surgery as well as non-surgical options. He also holds an appointment as Associate Clinical Professor at the Medical College of Virginia, Virginia Commonwealth University in the division of Urogynecology and serves as Director of Robotic Surgery at Johnston Willis Medical Center.

Nathan Guerette

Director & CEO and Director of Robotic Surgery
Female Pelvic Medicine Institute of Virginia and Johnston Willis Hospital

Nathan Guerette

Director & CEO and Director of Robotic Surgery
Female Pelvic Medicine Institute of Virginia and Johnston Willis Hospital

Dr. Nathan Guerette serves as Director and CEO of The Female Pelvic Medicine Institute of Virginia. He is a board certified Urogynecologist specializing in minimally invasive surgical options for pelvic reconstruction and cosmetic surgery including advanced vaginal and robotic surgery as well as non-surgical options. He also holds an appointment as Associate Clinical Professor at the Medical College of Virginia, Virginia Commonwealth University in the division of Urogynecology and serves as Director of Robotic Surgery at Johnston Willis Medical Center.

Prior to moving to Virginia, Dr. Guerette served as Director of Urogynecology at Pennsylvania Hospital, University of Pennsylvania in Philadelphia. Dr. Guerette is board certified in Female Pelvic Medicine and Reconstructive Surgery, Obstetrics and Gynecology as well as Family Medicine. He completed his Fellowship in Female Pelvic Medicine and Reconstructive Pelvic Surgery at the Cleveland Clinic Foundation in 2005 and is the first fellowship trained, board certified Urogynecologist in Central Virginia.

 

 

Minh Ngo

Women’s Rights Advocate, Board of Directors
Friends of UNFPA

Minh Ngo is a social justice and women's rights activist, philanthropic leader and social entrepreneur based in Silicon Valley. She has worked with nonprofit organizations, government agencies, and private sector partners to solve intractable problems facing communities. She currently serves as the Executive Director of My New Red Shoes, Board Member and Immediate Past Board Chair of Friends of UNFPA (United Nations Population Fund) and as an Advisor to Community Equity Collaborative, based in Menlo Park. Ms.

Minh Ngo

Women’s Rights Advocate, Board of Directors
Friends of UNFPA

Minh Ngo

Women’s Rights Advocate, Board of Directors
Friends of UNFPA

Minh Ngo is a social justice and women's rights activist, philanthropic leader and social entrepreneur based in Silicon Valley. She has worked with nonprofit organizations, government agencies, and private sector partners to solve intractable problems facing communities. She currently serves as the Executive Director of My New Red Shoes, Board Member and Immediate Past Board Chair of Friends of UNFPA (United Nations Population Fund) and as an Advisor to Community Equity Collaborative, based in Menlo Park. Ms. Ngo is a graduate of the University of California at Berkeley and Santa Clara University’s School of Law.

 

Jenny Yip

Managing Partner
Adjuvant Capital

Jenny Yip

Managing Partner
Adjuvant Capital

Jenny Yip

Managing Partner
Adjuvant Capital
 

Dr. Brian A. Bernick

Co-Founder & Chief Scientific Officer
TherapeuticsMD

Dr. Brian Bernick is a graduate of Northwestern University where he was pre-med and earned a degree in economics.  Dr. Bernick graduated from Chicago Medical School and then went on to specialize in obstetrics and gynecology, completing his residency through the University of Pennsylvania.  Thereafter, Dr.

Dr. Brian A. Bernick

Co-Founder & Chief Scientific Officer
TherapeuticsMD

Dr. Brian A. Bernick

Co-Founder & Chief Scientific Officer
TherapeuticsMD

Dr. Brian Bernick is a graduate of Northwestern University where he was pre-med and earned a degree in economics.  Dr. Bernick graduated from Chicago Medical School and then went on to specialize in obstetrics and gynecology, completing his residency through the University of Pennsylvania.  Thereafter, Dr. Bernick spent over 20 years in private practice in Boca Raton, Florida.  During that time, he served as the Chairman of the Department of Obstetrics and Gynecology at Boca Raton Regional Hospital and as an associate professor at Florida Atlantic University College of Medicine.  In 2008, Dr. Bernick co-founded TherapeuticsMD, a woman’s healthcare company where he has remained part of the executive management and oversees product development and outreach with healthcare providers.  TherapeuticsMD is a NASDAQ traded pharmaceutical company with prescription drug products ranging from prenatal care, contraception and menopause. In 2018, TherapeuticsMD obtained 3 new drug approvals. Dr. Bernick is the recipient of several national and regional awards, including recognition by his peers as one of the top doctor’s in his specialty. Dr. Bernick has over 100 peer-reviewed publications and presentations of original research at medical conferences. Dr. Bernick holds over 40 US and foreign patents focusing on drug therapies and analysis.  Dr. Bernick resides in Boca Raton, Florida with his wife and two kids.

 

 

 

Sherrie Palm

Founder & CEO
Association for Pelvic Organ Prolapse Support

ENGENDERING THE NEXT SIGNIFICANT SHIFT IN WOMEN’S HEALTH DIRECTIVES               
Sherrie Palm carves the trail to de-stigmatize pelvic organ prolapse (POP), a common but rarely acknowledged women’s health condition impacting an estimated 50% of women, as she educates and inspires regarding the evolution of women’s vaginal and intimate health awareness.

 

Sherrie Palm

Founder & CEO
Association for Pelvic Organ Prolapse Support

Sherrie Palm

Founder & CEO
Association for Pelvic Organ Prolapse Support

ENGENDERING THE NEXT SIGNIFICANT SHIFT IN WOMEN’S HEALTH DIRECTIVES               
Sherrie Palm carves the trail to de-stigmatize pelvic organ prolapse (POP), a common but rarely acknowledged women’s health condition impacting an estimated 50% of women, as she educates and inspires regarding the evolution of women’s vaginal and intimate health awareness.

 

Sherrie Palm is the Founder/CEO of APOPS, Association for Pelvic Organ Prolapse Support, author of 3 editions of the award-winning book Pelvic Organ Prolapse: The Silent Epidemic, an internationally recognized speaker, pelvic organ prolapse advocate, vaginal and intimate health activist, POP key opinion leader, and prolific writer regarding POP physical, emotional, social, sexual, fitness, and employment quality of life impact.

 

Sherrie has presented speeches nationally and internationally to physician, research, academic, corporate, policy and patient audiences since 2011.  Her points of focus are raising awareness of the next significant evolution in women’s health awareness, screening, practice, and policy, advancing global women’s vaginal and intimate health understanding, developing POP patient guidance and support structures, and bridge building within patient advocacy, white coat, and white collar sectors toward the advancement of women’s pelvic health and POP best practices.

                                                                                                                                                                     

Recognizing a need to shift the global view of the remaining stigmatized aspects of women’s health, Sherrie Palm takes steps to pioneer change. Cognizant of the diverse and sensitive needs of her audience, Sherrie delicately places all the cards on the table to disclose aspects of vaginal health and intimate wellness rarely effectively discussed.  Sherrie’s capacity to respectfully and compassionately answer all questions posed during speaking engagements endears her to the audience.

 

Sherrie’s engagement in POP projects and protocol enables patient voice to be an integral part of women’s health and wellness evolution. Sherrie presented to the FDA Obstetrics and Gynecology Advisory Committee Panel transvaginal mesh complication meetings in 2011 and 2019, sat on the Pelvic Floor Disorders Stakeholder Advisory Committee from 2011-2013, and currently sits on the FDA Medical Device Epidemiology Network (MDEpiNET) committee. Additional information about APOPS, pelvic organ prolapse, or Ms. Palm’s book or speaking presentations is available on the APOPS website.

 

http://www.pelvicorganprolapsesupport.org/sherrie-palm/

[email protected]

 

Josie Elias

Program Manager – Digital Health Innovation Group
Brigham and Women’s Hospital

Josie Elias

Program Manager – Digital Health Innovation Group
Brigham and Women’s Hospital

Josie Elias

Program Manager – Digital Health Innovation Group
Brigham and Women’s Hospital
 

Mika Nishimura

Operational Partner
Gilde Healthcare

Mika Nishimura is a seasoned senior executive with over 20 years of leadership experience in medical device industry.

During her tenure as the Director of Global Marketing at Guidant Vascular Intervention and Vice President, International Sales Operations and Marketing at ev3, Inc., Ms. Nishimura started and built franchises contributing significant, consistent revenue and profit growth with operations in over 30 markets.

Mika Nishimura

Operational Partner
Gilde Healthcare

Mika Nishimura

Operational Partner
Gilde Healthcare

Mika Nishimura is a seasoned senior executive with over 20 years of leadership experience in medical device industry.

During her tenure as the Director of Global Marketing at Guidant Vascular Intervention and Vice President, International Sales Operations and Marketing at ev3, Inc., Ms. Nishimura started and built franchises contributing significant, consistent revenue and profit growth with operations in over 30 markets.

In 1999, Ms. Nishimura founded The BLG Group, a leading consulting practice advising both investors and device companies. Her clients have sought her group’s advice on critical strategic initiatives ranging from identifying high-priority acquisition targets, developing a product/technology road map based on rigorous analyses and strategic thinking, or creating and executing a geographical expansion plan.  She is a frequent speaker at medical device and life science conferences.

In April 2011, Ms. Nishimura became Vice President, Commercial Development for Auxogyn, Inc., an early-stage life science company focused on improving success rates of in-vitro fertilization procedures.

Ms. Nishimura holds an MBA from the Harvard Business School and a BA in Economics with distinction, summa cum laude from Yale University.

 

Armida Valles-Klute

Executive Director of Managed Care and Financial Clearance
Dell Medical School

Armida Valles-Klute

Executive Director of Managed Care and Financial Clearance
Dell Medical School

Armida Valles-Klute

Executive Director of Managed Care and Financial Clearance
Dell Medical School
 

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth
 

Kristina Cahojova

CEO
Kegg

Kristina Cahojova

CEO
Kegg

Kristina Cahojova

CEO
Kegg
 

Dr Taraneh Shirazian

Gynaecologic Surgeon, Assistant Professor Center; President and Founder, Saving Mothers
NYU Langone Medical

As a board certified gynecologist at NYU Langone, I specialize in minimally invasive gynecologic surgery and the management of many common health issues affecting women. These include uterine fibroids, ovarian cysts, abnormal uterine bleeding, abnormal pap smears, uterine prolapse, and menopause. I also treat women who have received an abnormal Pap test result.

In the office, I perform procedures such as loop electrosurgical excision to diagnose abnormal or cancerous conditions, hysteroscopy to examine the uterus, and colposcopy to examine the cervix, vagina, and vulva.

Dr Taraneh Shirazian

Gynaecologic Surgeon, Assistant Professor Center; President and Founder, Saving Mothers
NYU Langone Medical

Dr Taraneh Shirazian

Gynaecologic Surgeon, Assistant Professor Center; President and Founder, Saving Mothers
NYU Langone Medical

As a board certified gynecologist at NYU Langone, I specialize in minimally invasive gynecologic surgery and the management of many common health issues affecting women. These include uterine fibroids, ovarian cysts, abnormal uterine bleeding, abnormal pap smears, uterine prolapse, and menopause. I also treat women who have received an abnormal Pap test result.

In the office, I perform procedures such as loop electrosurgical excision to diagnose abnormal or cancerous conditions, hysteroscopy to examine the uterus, and colposcopy to examine the cervix, vagina, and vulva.

I perform all types of surgeries for benign gynecological conditions, such as endometriosis, uterine fibroids, and ovarian cysts. These procedures include laparoscopic, minimally invasive surgeries, such as myomectomy, hysterectomy, and ovarian cystectomy.

In my practice, I emphasize patient education and empowerment. I take the time to ensure that every woman I see understands the details of her condition and has the knowledge to make the best decisions about treatment.

As the director of Global Women’s Health in NYU’s College of Global Public Health, I actively research and raise awareness about global health and women’s health issues. I also serve as the president and medical director of Saving Mothers, a nonprofit organization I founded that focuses on women’s health, education, and empowerment in low resource regions.

My research focuses on interventions that can help to reduce the number of women who die during pregnancy or childbirth around the world. In addition, I have coauthored a book, Around the Globe for Women’s Health: A Practical Guide for the Health Care Provider, and am frequently called on for my expertise in women’s health by national media outlets, such as CBS News, The Today Show, and Good Morning America. I have been quoted in the Wall Street JournalWomen’s DayNewsweek, and the New York Daily News.

Through the treatment I offer to patients, as well as my research and engagement with media outlets, I always strive to be an advocate for women, both locally and globally, and to champion women’s health education and self-empowerment.

 

 

Aarathi Singh

Chief Operations Officer
Medgyn

Aarathi Singh is a senior executive in the medical device industry with 15+ years of strategy and operating experience. She has a strong background in marketing, sales force optimization, and the commercialization of innovative technologies. Aarathi is Chief Operating Officer of MedGyn, a global manufacturer and distributor for women’s health products.

Aarathi Singh

Chief Operations Officer
Medgyn

Aarathi Singh

Chief Operations Officer
Medgyn

Aarathi Singh is a senior executive in the medical device industry with 15+ years of strategy and operating experience. She has a strong background in marketing, sales force optimization, and the commercialization of innovative technologies. Aarathi is Chief Operating Officer of MedGyn, a global manufacturer and distributor for women’s health products. Through Aarathi’s leadership the company has expanded into international markets and new product lines to address the unmet needs in women’s health throughout the world, including partnerships with governments, NGOs, and leading healthcare organizations. Prior to joining MedGyn, Aarathi held positions of increasing responsibility at Deloitte Consulting and at Johnson & Johnson. Aarathi has a BS in Finance from Boston University and a MBA from Northwestern University Kellogg School of Management.

https://profiles.forbes.com/members/business/profile/Aarathi-Singh-Chief-Operating-Officer-MedGyn-Products-Inc/d3266977-8ed8-4278-abb8-e1780cea8884

 

Dr Jin Lee, Ph.D

Director Digital Health Product / Commercial Strategy
Astellas Pharma

Dr. Jin Lee is the Director of Digital Health Product/ Commercial Strategy at Astellas pharma. She most recently was the CEO and founder of BabyNoggin, a maternal/child app platform screening for postpartum depression and child’s development issues and help those connect to additional care as needed. She was formerly at the innovation centers and venture arms of Humana, 4th largest health insurance company, and Providence St. Joseph Health, 3rd largest nonprofit hospital system, focused on series A & B digital health investments. Based in San Francisco, Dr.

Dr Jin Lee, Ph.D

Director Digital Health Product / Commercial Strategy
Astellas Pharma

Dr Jin Lee, Ph.D

Director Digital Health Product / Commercial Strategy
Astellas Pharma

Dr. Jin Lee is the Director of Digital Health Product/ Commercial Strategy at Astellas pharma. She most recently was the CEO and founder of BabyNoggin, a maternal/child app platform screening for postpartum depression and child’s development issues and help those connect to additional care as needed. She was formerly at the innovation centers and venture arms of Humana, 4th largest health insurance company, and Providence St. Joseph Health, 3rd largest nonprofit hospital system, focused on series A & B digital health investments. Based in San Francisco, Dr. Lee advises multiple digital health startups and accelerator programs. She received her Ph.D in neuropsychology from the University of Oxford and BA in biology and neuroscience from the University of Pennsylvania.

 

Jarrad Aguirre, MD, MBA

Head of Corporate Strategy and Advocacy
Myovant Sciences

Jarrad Aguirre, MD, MBA, is Head of Corporate Strategy and Advocacy at Myovant Sciences, a healthcare company focused on women's health and prostate cancer. In this role, he oversees corporate communications, patient advocacy, and digital strategy, and serves on the Executive Committee. 
 

Jarrad Aguirre, MD, MBA

Head of Corporate Strategy and Advocacy
Myovant Sciences

Jarrad Aguirre, MD, MBA

Head of Corporate Strategy and Advocacy
Myovant Sciences

Jarrad Aguirre, MD, MBA, is Head of Corporate Strategy and Advocacy at Myovant Sciences, a healthcare company focused on women's health and prostate cancer. In this role, he oversees corporate communications, patient advocacy, and digital strategy, and serves on the Executive Committee. 
 
Prior to joining Myovant, Jarrad worked as a physician, researcher, and consultant across the spectrum of health and healthcare, including at Brigham and Women's Hospital (a teaching hospital of Harvard Medical School), The Colorado Health Foundation, the Bill & Melinda Gates Foundation, and Collective Health. 
 
He graduated with honors from Yale University and University of Oxford, where he studied as a Rhodes Scholar. He completed the MD/MBA at Stanford University, supported by the Jack Kent Cooke Foundation Graduate Scholarship.  

 

 

Lisa Larkin

CEO & Founder
Ms Medicine

Lisa Larkin

CEO & Founder
Ms Medicine

Lisa Larkin

CEO & Founder
Ms Medicine
 

Sofia Noori MD, MPH

Yale Psychiatry Resident, Digital Mental Health
Yale Psychiatry Department

Dr. Sofia Noori is a third-year resident physician in the Yale Department of Psychiatry. At Yale she serves as the curriculum lead for Innovation to Impact, a NIDA-funded substance use entrepreneurship program that helps addiction researchers and clinicians commercialize their insights for the public good.  She is a founding member of the Center for Digital Psychiatry at the Connecticut Mental Health Center, which aims to integrate digital health in the care of patients with serious mental illness. Dr.

Sofia Noori MD, MPH

Yale Psychiatry Resident, Digital Mental Health
Yale Psychiatry Department

Sofia Noori MD, MPH

Yale Psychiatry Resident, Digital Mental Health
Yale Psychiatry Department

Dr. Sofia Noori is a third-year resident physician in the Yale Department of Psychiatry. At Yale she serves as the curriculum lead for Innovation to Impact, a NIDA-funded substance use entrepreneurship program that helps addiction researchers and clinicians commercialize their insights for the public good.  She is a founding member of the Center for Digital Psychiatry at the Connecticut Mental Health Center, which aims to integrate digital health in the care of patients with serious mental illness. Dr. Noori is a 2019 scholar at Flare Capital Partners in Boston, MA.

 

Aside from her endeavors in digital health, Dr. Noori deeply cares about the wellbeing of women. She is the co-founder of the Women’s Mental Health Conference at Yale, the first trainee-led women’s mental health conference in the world.  Dr. Noori also co-founded the Yale Women’s Housestaff Organization, which advocates for improved working conditions for the over 700 women residents and fellows at Yale.

 

Dr. Noori is an MD graduate of the PRIME program at UCSF School of Medicine, a dual-degree program that trains emerging physician-leaders to transform care for underserved populations. She received her MPH in health policy and management at UC Berkeley. She is passionate about women’s mental health and the use of technology to improve health equity.  

 

 

Holly Rockweiler

Co-Founder & CEO
Madorra

Holly Rockweiler

Co-Founder & CEO
Madorra

Holly Rockweiler

Co-Founder & CEO
Madorra
 

Meghan Rivera

Vice President and Head of Sales & Marketing Women’s Health
AMAG Pharma

Meghan Rivera

Vice President and Head of Sales & Marketing Women’s Health
AMAG Pharma

Meghan Rivera

Vice President and Head of Sales & Marketing Women’s Health
AMAG Pharma
 

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital
 

Debra Bass

U.S. President and Chief Marketing Officer
Nuvo Group

Debra Bass

U.S. President and Chief Marketing Officer
Nuvo Group

Debra Bass

U.S. President and Chief Marketing Officer
Nuvo Group
 

Keren Leshem, MBA

CEO
OCON Healthcare

Seasoned executive with over 20 years' experience in the medical device & pharmaceutical industries specializing in the management of innovative start-ups, strategy, commercialization, BD and financing.

Keren Leshem, MBA

CEO
OCON Healthcare

Keren Leshem, MBA

CEO
OCON Healthcare

Seasoned executive with over 20 years' experience in the medical device & pharmaceutical industries specializing in the management of innovative start-ups, strategy, commercialization, BD and financing.

 

Hadine Joffe

Executive Director
Mary Horrigan Conners Center for Women’s Health and Gender Biology, Brigham and Women’s Hospital

Hadine Joffe

Executive Director
Mary Horrigan Conners Center for Women’s Health and Gender Biology, Brigham and Women’s Hospital

Hadine Joffe

Executive Director
Mary Horrigan Conners Center for Women’s Health and Gender Biology, Brigham and Women’s Hospital
 

Teo Tijerina

Founder & CEO
Hera Diagnostics

Teo Tijerina

Founder & CEO
Hera Diagnostics

Teo Tijerina

Founder & CEO
Hera Diagnostics
 

Anne Morrissey

Former President & CEO
Alydia Health

Anne Morrissey

Former President & CEO
Alydia Health

Anne Morrissey

Former President & CEO
Alydia Health
 

Eric Dy

Founder and CEO
Bloomlife

Eric Dy

Founder and CEO
Bloomlife

Eric Dy

Founder and CEO
Bloomlife
 

Marta Hill Gray

Founder & CEO
Gray Matter Group

Marta Hill Gray

Founder & CEO
Gray Matter Group

Marta Hill Gray

Founder & CEO
Gray Matter Group
 

Elizabeth Bailey

Director of Investments
Rhia Ventures

Elizabeth Bailey

Director of Investments
Rhia Ventures

Elizabeth Bailey

Director of Investments
Rhia Ventures
 

Tanya Abreu

Healthcare Futurist & Health Network Strategist
Healthy Women

Tanya Abreu

Healthcare Futurist & Health Network Strategist
Healthy Women

Tanya Abreu

Healthcare Futurist & Health Network Strategist
Healthy Women
 

Lawler Kang

Founder & CEO
League of Allies

I am presently running League of Allies, a professional services firm focused on helping our clients benefit from "inclusive synergy", the material improvement of both operating and investment performance generated by minimizing dominant culture groupthink. The League was profoundly influenced by researching my second book, The E Ticket.

Chief People Officer at Rue La La, a leading force in the evolution of e-commerce.

Lawler Kang

Founder & CEO
League of Allies

Lawler Kang

Founder & CEO
League of Allies

I am presently running League of Allies, a professional services firm focused on helping our clients benefit from "inclusive synergy", the material improvement of both operating and investment performance generated by minimizing dominant culture groupthink. The League was profoundly influenced by researching my second book, The E Ticket.

Chief People Officer at Rue La La, a leading force in the evolution of e-commerce.

Running People Strategy and Talent Acquisition for a health-care focused innovation software consultancy with offices in Cambridge, Washington DC, Trinidad, and Jamaica.

Authoring a book, Passion at Work (Pearson Prentice Hall) that led to a speaking/workshop business that has serviced organizations from startups to Fortune 50 concerns.

Running four turnarounds, from software/services to bio-tech.

Serving as an Engagement Manager in the venture funded business unit at Scient, an eBusiness consulting firm, and then Managing Director of the Northeast, growing the presence to 85 amazing Colleagues.

Staffing revolutions in an executive search capacity.

Specialties: Executive Management, Belonging/Engagement/Retention, Leadership, Start Ups, Motivational Speaking, Consulting, Strategy, Human Assets, Talent Acquisition, Turn Around Management, High-Growth Environments, Writing 

 

Ariana Tiwari

Associate Marketing Manager
Renew Life/Clorox

At Renew Life, Ariana Tiwari is responsible for developing and launching science-backed probiotic products, crafting innovative marketing campaigns highlighting women’s digestive issues, and building business cases for innovation focused on the female microbiome. Before joining Renew Life’s brand marketing team, she worked on infrastructure projects at the International Finance Corporation, a part of the World Bank Group, and on healthcare deals in the investment banking division of Credit Suisse.

Ariana Tiwari

Associate Marketing Manager
Renew Life/Clorox

Ariana Tiwari

Associate Marketing Manager
Renew Life/Clorox

At Renew Life, Ariana Tiwari is responsible for developing and launching science-backed probiotic products, crafting innovative marketing campaigns highlighting women’s digestive issues, and building business cases for innovation focused on the female microbiome. Before joining Renew Life’s brand marketing team, she worked on infrastructure projects at the International Finance Corporation, a part of the World Bank Group, and on healthcare deals in the investment banking division of Credit Suisse. In her spare time, she teaches yoga in San Francisco; launched the DC chapter of Off Their Plate, a non-profit that re-employs restaurant workers in order to feed healthcare professionals on the frontlines of fighting COVID-19; and aspires to taste every wine in Napa Valley. Ariana holds a B.A. from Princeton University and an M.B.A. from Harvard Business School. 

 

Zac Lewis, PhD

R&D Senior Scientist
Renew Life/Clorox

Zac is an R&D Senior Scientist for the Renew Life brand.

He holds a Ph.D. in Microbiology from the University of California, Davis; and was awarded a prestigious Alfred P. Sloan Foundation postdoctoral fellowship

Zac Lewis, PhD

R&D Senior Scientist
Renew Life/Clorox

Zac Lewis, PhD

R&D Senior Scientist
Renew Life/Clorox

Zac is an R&D Senior Scientist for the Renew Life brand.

He holds a Ph.D. in Microbiology from the University of California, Davis; and was awarded a prestigious Alfred P. Sloan Foundation postdoctoral fellowship

He has extensive expertise in Bi­fidobacterial genetics and physiology, as well as experience measuring bacterial abundances using state-of-the-art DNA sequencing techniques. He currently leads the development of probiotic and prebiotic products, and is the point person for Renew Life’s clinical trials program. He also provides subject matter expertise on the human microbiome.

 

Rob Royea

CEO & Co-Founder
Cyrcadia Asia

Rob Royea

CEO & Co-Founder
Cyrcadia Asia

Rob Royea

CEO & Co-Founder
Cyrcadia Asia
 

Colette Courtion

CEO and Founder
JoyLux

Colette Courtion

CEO and Founder
JoyLux

Colette Courtion

CEO and Founder
JoyLux
 

Liz Klinger

CEO
Lioness

Liz Klinger

CEO
Lioness

Liz Klinger

CEO
Lioness
 

Trish Costello

Founder & CEO
Portfolia

Ms. Costello is founder and CEO of Portfolia, which offers a radically different investing process designed for women and other emerging investors. She is also co-founder and CEO Emeritus of the Kauffman Fellows Program, Center for Venture Education, the global educational institute preparing the leaders of the venture capital industry, located in Palo Alto, CA. Portfolia brings investing into the 21st Century, creating entrepreneurial funds focused where women make markets, such as women's health, active aging, consumer, enterprise, food & agtech, and fashion, tech and beauty.

Trish Costello

Founder & CEO
Portfolia

Trish Costello

Founder & CEO
Portfolia

Ms. Costello is founder and CEO of Portfolia, which offers a radically different investing process designed for women and other emerging investors. She is also co-founder and CEO Emeritus of the Kauffman Fellows Program, Center for Venture Education, the global educational institute preparing the leaders of the venture capital industry, located in Palo Alto, CA. Portfolia brings investing into the 21st Century, creating entrepreneurial funds focused where women make markets, such as women's health, active aging, consumer, enterprise, food & agtech, and fashion, tech and beauty. The investing experience is smart, personalized, and educational, providing returns and market impact customized to your interests. Portfolia is building a powerful global community of sophisticated investors focusing their money and influence to build the world they want.

 

Elizabeth Jeffords

Chief Commercial & Strategy Officer
Alkahest

Elizabeth Jeffords

Chief Commercial & Strategy Officer
Alkahest

Elizabeth Jeffords

Chief Commercial & Strategy Officer
Alkahest
 

Linda Greub

General Partner
Avestria

Linda Greub

General Partner
Avestria

Linda Greub

General Partner
Avestria
 

Leah Sparks

CEO & Founder
Wildflower Health

Leah Sparks, CEO & Founder of Wildflower Health, has more than 15 years experience building innovative healthcare businesses in both venture-backed companies and Fortune 50 corporations.  Leah founded Wildflower Health in 2012 while starting a family of her own and seeing firsthand the gaps in healthcare for consumers. 

Leah Sparks

CEO & Founder
Wildflower Health

Leah Sparks

CEO & Founder
Wildflower Health

Leah Sparks, CEO & Founder of Wildflower Health, has more than 15 years experience building innovative healthcare businesses in both venture-backed companies and Fortune 50 corporations.  Leah founded Wildflower Health in 2012 while starting a family of her own and seeing firsthand the gaps in healthcare for consumers. 

Prior to starting Wildflower Health, Leah led business development for a personalized medicine startup that was acquired by Medco a few years after she joined the company.  She began her career in healthcare at McKesson Corporation in corporate development, where she focused on strategy and M&A.  During her tenure at McKesson, she held a variety of leadership roles including spearheading the company’s entry into the oncology market.

 

Dr Benjamin Brucker, MD

Urologist, MD
NYU Langone Health

One of my grandfathers was a general surgeon and the other was an obstetrician—I chose a specialty that is the perfect blend of their fields. I specialize in urology, urogynecology, and surgery, and I help to manage bladder problems, incontinence, urinary tract infections, pelvic organ prolapse, and other conditions.

Dr Benjamin Brucker, MD

Urologist, MD
NYU Langone Health

Dr Benjamin Brucker, MD

Urologist, MD
NYU Langone Health

One of my grandfathers was a general surgeon and the other was an obstetrician—I chose a specialty that is the perfect blend of their fields. I specialize in urology, urogynecology, and surgery, and I help to manage bladder problems, incontinence, urinary tract infections, pelvic organ prolapse, and other conditions.

I use a combination of traditional approaches and advanced, minimally invasive techniques to improve safety, speed of recovery, and outcomes for my patients. I maintain wonderful relationships with my patients and find it incredibly rewarding to help them by managing their conditions and performing surgeries.

It is vital for physicians to completely understand how a condition affects a patient. To do so, we must be familiar with the person’s overall health, sense of wellbeing, and quality of life, as well as the impact of the condition on the person’s relationships and families.

Having this information helps me to create individualized treatment plans. Treatments cannot be “one size fits all,” because every patient experience is unique. Our team, regarded as one of the best in the world, pays close attention to each person’s needs and diagnosis.

In addition to treating patients, I conduct research on incontinence, the effects of multiple sclerosis and neurologic disorders on the bladder, and treatment of people with overactive bladder and benign prostatic hyperplasia, or an enlarged prostate. I’m very fortunate to have received a grant from the Allergan Foundation to continue my research on incontinence. This funding also enables me to train future leaders in the field.

I am proud to have been selected by Super Doctors for a “Rising Star” distinction in the New York Metro area and by The Leading Physicians of the World for a “Top Urologist” award.

 

 

Amy Beckley

CEO
MFB Fertility

Amy has a PhD in Pharmacology and expertise in hormone signaling. She also had a three year battle with infertility. After self-diagnosing her own causes of infertility and saving herself from more rounds of in vitro fertilization (IVF),  she invented Proov to help women have access to their hormonal health to conceive faster

Amy Beckley

CEO
MFB Fertility

Amy Beckley

CEO
MFB Fertility

Amy has a PhD in Pharmacology and expertise in hormone signaling. She also had a three year battle with infertility. After self-diagnosing her own causes of infertility and saving herself from more rounds of in vitro fertilization (IVF),  she invented Proov to help women have access to their hormonal health to conceive faster

 

Nicole Leeds

Go-To-Business Strategy
Clue (digital period tracker)

Nicole is the Head of Monetization and New Business at Clue, where she focuses on new revenue models, B2B partnerships, and company strategy. With over 12 million users worldwide, Clue is one of the most popular apps in the health category and has been rated the top free period tracker app by the journal Obstetrics & Gynecology, a publication of the American College of Obstetricians and Gynecologists (ACOG).

Nicole Leeds

Go-To-Business Strategy
Clue (digital period tracker)

Nicole Leeds

Go-To-Business Strategy
Clue (digital period tracker)

Nicole is the Head of Monetization and New Business at Clue, where she focuses on new revenue models, B2B partnerships, and company strategy. With over 12 million users worldwide, Clue is one of the most popular apps in the health category and has been rated the top free period tracker app by the journal Obstetrics & Gynecology, a publication of the American College of Obstetricians and Gynecologists (ACOG).

Nicole has previously worked in digital health, medical devices, and global development in Germany, India, Rwanda and the United States. Her background includes the international medical devices business on Medtronic's corporate strategy team, global health equity work with the Global Health Corps and the Clinton Health Access Initiative, and strategy consulting with the Bridgespan Group.

 

Dr. Raoul Scherwitzl

Co-Founder & CEO

Dr. Raoul Scherwitzl

Co-Founder & CEO

Dr. Raoul Scherwitzl

Co-Founder & CEO
 

Jeff Trost

Managing Partner
Laerdal Million Lives Fund

Jeff Trost

Managing Partner
Laerdal Million Lives Fund

Jeff Trost

Managing Partner
Laerdal Million Lives Fund

2020 Selection Committee

Jeff Trost

Managing Partner
Laerdal Million Lives Fund

Chandra P. Leo

Partner
HBM Partners

Elizabeth Bailey

Director of Investments
Rhia Ventures

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Stephen Gerrard

Program Officer
Bill & Melinda Gates Foundation

Elizabeth Jeffords

Chief Commercial & Strategy Officer
Alkahest

Linda Greub

General Partner
Avestria

Tenesha Duncan

Principal, Maternal Health
Tara Health Foundation

Jenny Yip

Managing Partner
Adjuvant Capital

Trish Costello

Founder & CEO
Portfolia

2020 Steering Committee

Susan C. Nicholson, MD, FIDSA

Vice President, Women’s Health
Johnson & Johnson

Alice Zheng, MD, MBA, MPH

Women’s Health Practice Leader
McKinsey & Company

Stephen Gerrard

Program Officer
Bill & Melinda Gates Foundation

Luba Greenwood

Co-Founder & Board Member, Former Strategic BD & Corporate Ventures at Verily
LUCA

Meghan Rivera

Vice President and Head of Sales & Marketing Women’s Health
AMAG Pharma

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Jarrad Aguirre

Head of Corporate Strategy and Advocacy
Myovant Sciences

Download agenda

Please complete the form to access the 2020 Women's Health Innovation Summit (WHIS) Agenda. 

Take a look at 2019 highlights:

Fill your details below

TICKET PACKAGES

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

Registration ends in

Monday, August 3, 2020 to Sunday, August 30, 2020
4 DAY PASS: START-UPS & INVESTORS (less than $10 million)
$399
Early Bird pricing until August 30th, Standard Price $499
4 Day Access
FemTech & Digital Health Companies, incl. Venture Capital, Angel Investors
Networking & 1-2-1 meetings
Want to partner? Contact [email protected]
Monday, August 3, 2020 to Sunday, August 30, 2020
4 DAY PASS: INDUSTRY
$799
Early Bird pricing until August 30th, Standard Price $999
4 Day Access
Pharma, Biotech, Medical Devices, Multinational & Corporate (over $10 million)
Networking & 1-2-1 meetings
Want to partner? Contact [email protected]
Monday, August 3, 2020 to Sunday, August 30, 2020
4 DAY PASS: SERVICE PROVIDERS
$899
Early Bird pricing until August 30th, Standard Price $1099
4 Day Access
Consultants & Industry Vendors, Investment Banks, Private Equity
Networking & 1-2-1 meetings
Want to partner? Contact [email protected]
Innovators: Virtual Display Package
$1300
Includes 2 Passes (Start-ups Only)
X2 Event Passes
4 Day Access
Early Access to 1-2-1 Networking Platform (to book meetings)
Video on the event Innovation Hub highlighting your innovation/solution
Preparing registration...

Clinical Research Partner

Associate Partner

Event Partner

KNOWLEDGE PARTNER

2019 Media Partners

BECOME A MEDIA PARTNER

If you're interested in becoming a media partner, please contact Madison Hill: [email protected]ch.com

Become a Sponsor

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

Venue

Virtual Event & 1-2-1 Meeting Platform

The second annual Women's Health Innovation Summit will be taking place digitally. You can access the event from anywhere in the world - including your living room! 

Join us on our ultra engaging Virtual Event & 1-2-1 Meeting Platform. 

  • Ask questions, vote in polls and participate in group discussions in real time
  • Greater access to attendees - see them all and send them a direct message
  • Participate in round tables, games, interative sessions or just listen to our world leading speakers
  • Endless possibilities to achieve your business and personal objectives with us online 

Got questions? Send us an email at [email protected]

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Other events you might be interested in:

Personalized Beauty Summit 2021